News Headlines

• J&J Adds Mortality Risk to Heart Drug Label
  ... NEW YORK (Reuters) - Johnson & Johnson has revised the label of its Natrecor heart failure medicine to include data that suggest it may increase the risk of death, following two widely publicized medical journal articles that questioned its safety....
  Reuters - Mon, 25 Apr 2005 06:07 EST
  
• J&J Adds Mortality Risk to Heart Drug Label
  ... NEW YORK (Reuters) - Johnson & Johnson has revised the label of its Natrecor heart failure medicine to include data that suggest it may increase the risk of death, following two widely publicized medical journal articles that questioned its safety....
  Reuters - Mon, 25 Apr 2005 09:06 EST
  
• J&J adds new info on clots to contraceptive patch
  ... WASHINGTON (Reuters) - Johnson & Johnson's Ortho Evra contraceptive patch will come with a new warning about a study suggesting users could face twice the risks of blood clots compared with birth control pills, the company and U.S. regulators said on Wednesday....
  Reuters - Wed, 20 Sep 2006 06:20 EST
  
• J&J campaigns for coverage of obesity surgery
  ...CLEVELAND, Ohio (Reuters) - The new head of Johnson & Johnson's surgical-device unit is campaigning to convince employers to cover an increasingly popular but pricey surgery for obesity....
  Reuters - Fri, 13 Oct 2006 01:08 EST
  
• J&J campaigns for coverage of obesity surgery
  ...CLEVELAND, Ohio (Reuters) - The new head of Johnson & Johnson's surgical-device unit is campaigning to convince employers to cover an increasingly popular but pricey surgery for obesity....
  Reuters - Fri, 13 Oct 2006 01:08 EST
  
• J&J campaigns for coverage of obesity surgery
  ...CLEVELAND, Ohio (Reuters) - The new head of Johnson & Johnson's surgical-device unit is campaigning to convince employers to cover an increasingly popular but pricey surgery for obesity....
  Reuters - Fri, 13 Oct 2006 01:08 EST
  
• J&J Changes Heart Drug Label to Show Mortality Risk
  ... NEW YORK (Reuters) - Johnson & Johnson on Monday said it had revised the label of its Natrecor medicine to indicate it increased the risk of death within 30 days after patients were treated with it for heart failure, compared with standard treatments....
  Reuters - Mon, 25 Apr 2005 04:35 EST
  
• J&J contraceptive patch to carry warning on blood clots
  ...The U.S. Food and Drug Administration has updated a warning on Johnson & Johnson's contraceptive patch Ortho Evra based on a study that suggested users could be exposed to twice the risk of blood clots compared with traditional birth control pills. The product will now carry a label to this effect, the FDA and the company said Wednesday....
  The Earth Times - Thu, 21 Sep 2006 09:02 EST
  
• J&J drug for Crohn's disease approved
  ... WASHINGTON (Reuters) - U.S. regulators approved wider use of Johnson & Johnson's drug Remicade on Friday but also said a new warning was being added about reports of an often-fatal lymphoma in a small number of users....
  Reuters - Fri, 19 May 2006 07:55 EST
  
• J&J drug for Crohn's disease approved
  ... WASHINGTON (Reuters) - U.S. regulators approved wider use of Johnson & Johnson's drug Remicade on Friday but also said a new warning was being added about reports of an often-fatal lymphoma in a small number of users....
  Reuters - Fri, 19 May 2006 10:30 EST
  
• J&J psoriasis drug posts mixed results in trial
  ...NEW YORK (Reuters) - Johnson & Johnson said on Wednesday its new type of treatment for psoriasis was highly effective in a mid-stage trial, but was linked to an increased risk of serious adverse events, including heart attacks....
  Reuters - Thu, 08 Feb 2007 03:27 EST
  
• J&J recalls child Tylenol over packaging info
  ... NEW YORK (Reuters) - Johnson & Johnson on Friday said it was recalling several varieties of its Tylenol painkiller for children due to confusing packaging information that could lead to young patients being given overly high doses of the over-the-counter medicine....
  Reuters - Fri, 03 Jun 2005 01:30 EST
  
• J&J says FDA cancels review of antipsychotic drug
  ... LOS ANGELES (Reuters) - Johnson & Johnson said on Friday that the U.S. Food and Drug Administration has canceled a planned advisory committee review its experimental drug paliperidone ER, a continuous release pill for treatment of schizophrenia....
  Reuters - Fri, 21 Jul 2006 09:54 EST
  
• J&J says FDA rejects Risperdal as autism treatment
  ... CHICAGO (Reuters) - Johnson & Johnson said on Friday U.S. regulators rejected its application to market antipsychotic drug Risperdal for patients with autism....
  Reuters - Fri, 20 May 2005 02:57 EST
  
• J&J says two deaths unreported in Natrecor study
  ... NEW YORK (Reuters) - Johnson & Johnson''s Scios Inc. unit on Tuesday said it had informed U.S. regulators that a previously unreported two additional patients died 30 days after taking its Natrecor heart failure drug in a long-term study, adding to uncertainty about the drug''s safety....
  Reuters - Tue, 03 Jan 2006 06:59 EST
  
• J&J says two deaths unreported in Natrecor study
  ... NEW YORK (Reuters) - Johnson & Johnson''s Scios Inc. unit on Tuesday said it had informed U.S. regulators of two previously unreported deaths among patients taking its Natrecor heart failure drug in a prior study of the medicine....
  Reuters - Tue, 03 Jan 2006 08:47 EST
  
• J&J schizophrenia drug gets conditional approval
  ...NEW YORK (Reuters) - Johnson & Johnson on Friday said U.S. health regulators would not approve the company's next-generation schizophrenia drug, paliperidone extended-release, until certain conditions are met....
  Reuters - Fri, 29 Sep 2006 11:55 EST
  
• J&J wins OK to promote drug for autism symptoms
  ...WASHINGTON (Reuters) - Johnson & Johnson won U.S. clearance to promote its schizophrenia drug Risperdal for treating irritability in children and adolescents with autism, health officials said on Friday....
  Reuters - Fri, 06 Oct 2006 08:55 EST
  
• J.& J. Deal for Stent Maker Clouded by Patent Disputes
  ...Patent battles may keep Conor Medsystems’s stent from reaching the U.S. and could force it out of markets where it has already been approved....
  New York Times - Sat, 18 Nov 2006 02:26 EST
  
• J.&J. Passes on Raising Guidant Bid
  ...Johnson & Johnson let lapse a midnight deadline without raising its bid for Guidant, paving the way for Boston Scientific to emerge as the winner in the takeover battle....
  New York Times - Wed, 25 Jan 2006 03:00 EST
  
• Jab advice for tourists to India
  ...Tourists visiting areas of north India and Nepal affected by a Japanese encephalitis outbreak should be vaccinated, doctors say....
  BBC - Tue, 30 Aug 2005 02:00 EST
  
• Jab cuts hepatitis virus levels
  ...Scientists have harnessed genetic technology to develop a potent treatment for the liver disease hepatitis....
  BBC - Mon, 25 Jul 2005 02:21 EST
  
• Jabs link to autism 'dispelled'
  ...Mercury-based vaccines and MMR jabs do not lead to an increased risk of autism, a Canadian study says....
  BBC - Wed, 05 Jul 2006 10:58 EST
  
• JACC Publishes ERICA Trial Results Showing Ranexa(R) Reduces Angina Frequency And Nitroglycerin Consumption
  ... CV Therapeutics,Inc. (Nasdaq: CVTX) announced today that the Journal of the AmericanCollege of Cardiology (JACC) has published data from the Efficacy ofRanolazine In Chronic Angina (ERICA) trial. In the ERICA trial, Ranexa(R)(ranolazine extended-release tablets) significantly reduced anginafrequency (p=0.028) and nitoglycerin consumption (p=0. [click link for full article]...
  MedicalNewsToday - Tue, 20 Jun 2006 06:00 EST
  
• Jack Kevorkian to be paroled
  ...After more than eight years in prison, a frail Dr. Jack Kevorkian will be paroled in June with a promise that he won’t assist in any more suicides, a prison spokesman said Wednesday....
  MSNBC - Wed, 13 Dec 2006 09:32 EST
  
• Jack Russell registers to vote in N.Z. election
  ...It was almost inevitable New Zealand''s election would turn into a dog fight when you look at one of the country''s 2.83 million voters --  Toby the Jack Russell terrier....
  MSNBC - Fri, 23 Sep 2005 03:20 EST
  
• Jackie Chan says stop discrimination against people living with HIV/AIDS
  ... At the conclusion of his first mission to Viet Nam, UNICEF/ UNAIDS Goodwill Ambassador Jackie Chan called for an end to discrimination and stigma towards children and families infected or affected with HIV/AIDS... click link for more info....
  MedicalNewsToday - Tue, 26 Apr 2005 05:00 EST
  
• Jackson Laboratory Joins National Centers For Systems Biology Program With A New, "systems" Approach To Studying The Genetics Of Health And Disease
  ...A $15.1 million National Institutes of Health (NIH) grant has been awarded to a team of Jackson Laboratory researchers with a new, "systems" approach to studying the genetics of health and disease.The National Institute of General Medical Sciences (NIGMS) is awarding the five-year grant for $15,073,585 under a "National Centers for Systems Biology" program... click link for more info....
  MedicalNewsToday - Tue, 04 Apr 2006 07:00 EST
  
• Jackson Laboratory Researchers Show High BMI Doesn't Always Spell Obesity
  ...For years doctors have used the body mass index (BMI), a ratio of height and weight, to characterize the clinical weight status of their patients. The lower the number, the presumption goes, the leaner the person, and anyone with a BMI above 30 is characterized as obese and at high risk for the associated complications. [click link for full article]...
  MedicalNewsToday - Mon, 24 Jul 2006 05:00 EST
  
• Jackson, Lee Encourage Enrollment In Medicare Prescription Drug Benefit
  ...The Rev. Jesse Jackson, president of the Rainbow/PUSH Coalition, and Rep. Barbara Lee (D-Calif.) on Sunday in Oakland, Calif., encouraged Medicare beneficiaries to enroll in the prescription drug benefit, the San Francisco Chronicle reports. [click link for full article]...
  MedicalNewsToday - Thu, 21 Dec 2006 04:00 EST